Norton Scientific Inc clarifies the sales of its shares via Börse Frankfurt
It has come to Norton’s attention that a company called “Franz Watermann AG” purportedly operating from Belgium/Netherlands is engaged in fraudulent activities. Potential shareholders should be cautioned not to have any dealings with this firm and in the event of being solicited by this company they should advise Norton immediately.
Norton to Present at “New Approaches & Technologies to Improve Process Development, Manufacturing & Control” in India
Norton Scientific is pleased to have been chosen to present a paper at the Genetix Biotech Asia Pvt. Ltd 2011 Bio Conference to be held in three cities across India December 2011. Arun Prakash, the president of Genetix, expects a total of about 1,000 attendees based on last years successful conference.
The three cities and dates are:
- Dec 5 at HYDERABAD
- Dec 7 at PUNE
- Dec 9 at AHMEDABAD
The PAM ™ Zero will be available for view. Our Applications Lab Manager, Ms Anjali Sharma, will present a technical paper entitled “RAPID, COST EFFECTIVE APPROACH TO PROTEIN AGGREGATION STUDIES” using the new Norton Scientific PAM ™ Zero for fast protein aggregation screening prior to sending samples on to more expensive and time consuming tests that depend on having appropriate aggregation levels to be useful. To get a copy of the paper after the conference, please email sales@norsci.ca…
Please contact Genetix Biotech Asia Pvt. Ltd at +91-11-45027000 or via email at info@genetixbiotech.com for more details.
Click here to download conference details including the venue names:
Norton Scientific signs up Shoko America for US West Coast sales
Norton Scientific continues to increase US market penetration by now covering the entire US West Coast with one key distributor. The Company has signed a distribution agreement with Shoko America Inc of Torrance, CA. The parent company, Shoko Scientific of Japan, earlier signed on to distribute Norton products in Japan. Shoko is a great fit as they are involved with many scientific instruments including analytical products, chemical synthesis related products, purification and separation products and sample preparation equipments for liquid chromatography. They are a distributor for Wyatt Technologies where the PAM Zero can act as a quick and cost effective screening tool. Bryan Webb, President of Norton said “We are very pleased to add a great company such as Shoko America to our expanding Norton sales channels in the USA. With their leverage into the West Coast markets, we expect great things from this relationship and continue to build a comprehensive sales presence in the USA”.
Norton, based in Thorold, ON, is a leader in the development of innovative measurement tools to advance biotech and pharmaceutical research, unveiled the highly anticipated PAM Zero at PITTCON/Atlanta 2011 earlier this year. The PAM Zero is targeted at laboratories and universities around the world. As of June 3, 2011, Norton is traded on the Frankfurt Borse (http://www.boerse-frankfurt.de/EN/index.aspx?pageID=35&ISIN=CA66869Q1037) under the symbol NT3.
Norton’s compact hand-held unit, a protein aggregation monitor, was developed to study how proteins aggregate in solution. Norton’s strategy is to develop simple-to-use products that can be used by technicians, rather than analysts, and incorporated into laboratories own process control systems. Over the next few years, Norton is expecting to successfully introduce and commercialize a novel microfluidic-based analytical instrumentation line used in the expanding niche of macromolecular molar mass distributions and nano-particle sizing applications.
The Company’s new measurement systems will be used in a wide range of markets from healthcare, biomaterials and green industries to viticulture, including brewing.
Norton Scientific signs up Shoko Scientific Co Ltd to boost PAM Zero sales in Japan
Norton Scientific continues to accelerate the schedule for extending its sales distribution network across Asia. As part of this strategic objective, the Company recently inked a deal with Shoko Scientific Co Ltd of Yokohama City, Japan. Shoko have Sales Offices in Osaka, Tsukuba and Fukuoka as well as China and the US West Coast (Shoko America). They are involved with many scientific instruments including analytical products, chemical synthesis related products, purification and separation products and sample preparation equipments for liquid chromatography. Shoko is a distributor for Wyatt Technologies where the PAM Zero can act as a quick and cost effective screening tool. Bryan Webb, President of Norton said “We are very excited to add a company such as Shoko Scientific to our expanding Norton sales channels and are even more encouraged they have ordered their first PAM Zero, the new protein aggregation monitor that consumes just 0.0μl of precious sample. We expect great things from this relationship and continue to build a comprehensive sales presence in the Far East”.
Norton, based in Thorold, ON, is a leader in the development of innovative measurement tools to advance biotech and pharmaceutical research, unveiled the highly anticipated PAM Zero at PITTCON/Atlanta 2011. The PAM Zero is targeted at laboratories and universities around the world. As of June 3, 2011, Norton is traded on the Frankfurt Borse (http://www.boerse-frankfurt.de/EN/index.aspx?pageID=35&ISIN=CA66869Q1037) under the symbol NT3.
Norton’s compact hand-held unit, a protein aggregation monitor, was developed to study how proteins aggregate in solution. Norton’s strategy is to develop simple-to-use products that can be used by technicians, rather than analysts, and incorporated into laboratories own process control systems. Over the next few years, Norton is expecting to successfully introduce and commercialize a novel microfluidic-based analytical instrumentation line used in the expanding niche of macromolecular molar mass distributions and nano-particle sizing applications.
The Company’s new measurement systems will be used in a wide range of markets from healthcare, biomaterials and green industries to viticulture, including brewing.
Norton Scientific joins “Proteomics Innovation Network” via LinkedIn
Proteomics Innovation Network (PIN) of Service and Product Providers Formed
Thirteen proteomics service and product providers have formed the Proteomics Innovation Network this year, 2011. Based on a discussion started on LinkedIn, a professional networking site, a virtual conference was held and continues on a monthly basis.
The mission of the Proteomics Innovation Network (PIN) is to generate “from sample to discovery” solutions in all facets of proteomics, including expression, identification, characterization, interaction and function. Each member organization has complementary expertise, core technologies, and infrastructure to address critical unmet needs in biomarker and drug target discovery, personalized medicine, drug profiling and selective reaction monitoring.
The Network includes these founding organizations:
ProFACT Proteomics – Functional Proteomics Profiling and Prospecting
Norton Scientific – Making Light Work of Your Sizing Needs…
Eprogen – Mapping New Dimensions in Proteomics™
Neolomed Biosciences LLC – Biomarker and Clinical/pre-clinical services for Oncology
Focus Proteomics – 2D Electrophoresis Consulting & Contract Services
New England Peptide – Custom peptides and polyclonal antibodies
Ontario Cancer Biomarker Network – MS Selective Reaction Monitoring
Innova Proteomics – CRO protein analyses and identification by mass spectrometry
Dualsystems Biotech – Your partner for customized screening solutions
New Liberty Proteomics – Unprecedented Drug Discovery and Evaluation Services
Horluce BioConsulting – Consultancy focusing on Infectious Diseases and Proteomics
Australian Proteome Analysis Facility – CRO protein discovery and quantitation
Covaris Inc. – Advanced sample preparation systems for life and analytical sciences
